Actinium Pharmaceuticals (ATNM) Earnings Date, Estimates & Call Transcripts → War Over Taiwan? Protect Your Wealth NOW (From Behind the Markets) (Ad) Free ATNM Stock Alerts $6.85 +0.29 (+4.42%) (As of 01:07 PM ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartEarningsHeadlinesOwnershipShort InterestStock AnalysisAnalyst ForecastsChartEarningsHeadlinesOwnershipShort Interest Earnings SummaryUpcoming Earnings DateMay. 15EstimatedActual EPS (Mar. 29) -$0.33 Beat By $0.21 Consensus EPS (Mar. 29) -$0.54 Get Actinium Pharmaceuticals Earnings AlertsEnter your email address below to receive the latest news and earnings results for ATNM and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueATNM Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.ATNM Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Behind the MarketsWar Over Taiwan? Protect Your Wealth NOWWith tensions rapidly escalating, Taiwan could provide the spark at any moment. Don't let your financial future get caught in the crossfire unprepared.Access my report now >>> Actinium Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20242($0.42)$0.54$0.06Q2 20242($0.78)($0.46)($0.62)Q3 20242($0.77)($0.50)($0.64)Q4 20242($0.78)($0.55)($0.67)FY 20248($2.75)($0.97)($1.86)ATNM Earnings Date and InformationActinium Pharmaceuticals last released its quarterly earnings results on March 29th, 2024. The biotechnology company reported ($0.33) earnings per share for the quarter, topping the consensus estimate of ($0.54) by $0.21. The business had revenue of $0.08 million for the quarter. Actinium Pharmaceuticals has generated ($1.83) earnings per share over the last year (($1.83) diluted earnings per share). Earnings for Actinium Pharmaceuticals are expected to grow in the coming year, from ($1.87) to $0.97 per share. Actinium Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 15th, 2024 based off prior year's report dates.Read More Actinium Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 5/15/2024Estimated)------- 3/29/2024Q4 2023($0.54)($0.33)+$0.21($0.33)-$0.08 million11/2/2023Q3 2023-($0.49)($0.49)($0.49)--8/14/2023Q2 2023($0.50)($0.58)($0.08)($0.58)--5/15/2023Q1 2023($0.42)($0.43)($0.01)($0.43)--4/3/2023Q4 2022($0.41)($0.42)($0.01)($0.42)$5.17 million-11/14/2022Q3 2022($0.30)($0.38)($0.08)($0.38)$2.90 million$0.05 million Get the Latest News and Ratings for ATNM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Actinium Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 11/14/2022Q3 2022($0.30)($0.38)($0.08)($0.38)$2.90 million$0.05 million8/12/2022Q2 2022($0.23)($0.33)($0.10)($0.33)$1.85 million$0.05 million8/12/2022Q2 2022($0.23)($0.33)($0.10)($0.33)$1.85 million$0.05 million5/13/2022Q1 2022($0.31)($0.23)+$0.08($0.23)-$0.94 million5/13/2022Q1 2022($0.31)($0.23)+$0.08($0.23)-$0.94 million11/12/2021Q3 2021($0.29)($0.30)($0.01)($0.30)$0.28 million$0.23 million11/12/2021Q3 2021($0.29)($0.30)($0.01)($0.30)$0.28 million$0.23 million7/30/2021Q2 2021($0.30)($0.25)+$0.05($0.25)-$0.27 million7/30/2021Q2 2021($0.30)($0.25)+$0.05($0.25)-$0.27 million5/14/2021Q1 2021($0.35)($0.29)+$0.06($0.29)-$0.62 million5/14/2021Q1 2021($0.35)($0.29)+$0.06($0.29)-$0.62 million Actinium Pharmaceuticals Earnings - Frequently Asked Questions When is Actinium Pharmaceuticals's earnings date? Actinium Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 15th, 2024 based off last year's report dates. Learn more on ATNM's earnings history. Did Actinium Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, Actinium Pharmaceuticals (NYSEAMERICAN:ATNM) reported ($0.33) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.54) by $0.21. Learn more on analysts' earnings estimate vs. ATNM's actual earnings. How much revenue does Actinium Pharmaceuticals generate each year? Actinium Pharmaceuticals (NYSEAMERICAN:ATNM) has a recorded annual revenue of $80,000.00. How much profit does Actinium Pharmaceuticals generate each year? Actinium Pharmaceuticals (NYSEAMERICAN:ATNM) has a recorded net income of -$48.82 million. ATNM has generated -$1.83 earnings per share over the last four quarters. What is Actinium Pharmaceuticals's EPS forecast for next year? Actinium Pharmaceuticals's earnings are expected to grow from ($1.87) per share to $0.97 per share in the next year. More Earnings Resources from MarketBeat Related Companies: Aldeyra Therapeutics Earnings Results uniQure Earnings Results Ovid Therapeutics Earnings Results Vanda Pharmaceuticals Earnings Results Werewolf Therapeutics Earnings Results G1 Therapeutics Earnings Results Abeona Therapeutics Earnings Results AC Immune Earnings Results Galectin Therapeutics Earnings Results Design Therapeutics Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future OutlookCSX Co.: The Railroad Powering Ahead with an Earnings Beat What's Driving Tesla Lower Ahead of its Earnings?Blackrock vs. State Street: Earnings in a Volatile MarketWhat to Expect From the Q1 Earnings Reporting SeasonLululemon Stock Implodes Post Earnings, Guidance Muted This page (NYSEAMERICAN:ATNM) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsRich Dad Poor Dad Author Shocks Millions With 2024 Crash WarningAmerican Hartford Gold GroupEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Actinium Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
